Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 12,050 shares at $91.83 ($1.1M) on 2014-01-10, disclosed to the SEC on 2014-01-14.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.83 | 12,000 | $1.1M | 99.6% |
| 2 | $92.85 | 50 | $5K | 0.4% |
| Total | $91.83 avg | 12,050 | $1.1M | 100% |
| Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |
| SLXP | BUY | 2011-08-11 | $21K | — | Filing → |